Cilostazol for prevention of secondary stroke (CSPS 2): an aspirin-controlled, double-blind, randomised non-inferiority trial-Reference-Cited by-同舟云学术

Cilostazol for prevention of secondary stroke (CSPS 2): an aspirin-controlled, double-blind, randomised non-inferiority trial

Published:2010-10 Issue:10 Volume:9 Page:959-968
ISSN:1474-4422
Container-title:The Lancet Neurology
language:en
Short-container-title:The Lancet Neurology

Author:

Shinohara Yukito,Katayama Yasuo,Uchiyama Shinichiro,Yamaguchi Takenori,Handa Shunnosuke,Matsuoka Kempei,Ohashi Yasuo,Tanahashi Norio,Yamamoto Hiroko,Genka Chokoh,Kitagawa Yasuhisa,Kusuoka Hideo,Nishimaru Katsuya,Tsushima Motoo,Koretsune Yukihiro,Sawada Tohru,Hamada Chikuma

Publisher

Elsevier BV

Subject

Neurology (clinical)

Reference34 articles.

1. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients;BMJ,2002

2. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE);Lancet,1996

3. Antiplatelet therapy for secondary prevention of noncardioembolic ischemic stroke: a critical review;O'Donnell;Stroke,2008

4. Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial;Diener;Lancet,2004

5. Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events;Bhatt;N Engl J Med,2006

Cited by 439 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Platelet Aggregation Test is Useful for Predicting Postprocedural Bleeding after Gastric Endoscopic Submucosal Dissection under Continuous Antiplatelet Agents;2024-08-17

2. Blood pressure during long-term cilostazol-based dual antiplatelet therapy after stroke: a post hoc analysis of the CSPS.com trial;Hypertension Research;2024-07-09

3. Cerebrovascular Effects of Sildenafil in Small Vessel Disease: The OxHARP Trial;Circulation Research;2024-07-05

4. The pharmacology of antiplatelet agents for primary, secondary, and tertiary prevention of ischemic stroke;Expert Opinion on Pharmacotherapy;2024-07-02

5. Review of Updated Guidelines and Evidence for Antithrombotic Therapy in Acute Ischemic Stroke;Korean Journal of Clinical Pharmacy;2024-06-30